Ligita Jančorienė
机构：Vilnius University · ORCID：0000-0001-6488-6312
发表论文 127 篇 · 总被引 1401 次 · h-index 17
代表论文
- Direct-acting antiviral therapies for hepatitis C infection: global registration, reimbursement, and restrictions (2024 · The Lancet. Gastroenterology & hepatology · 被引 73)
- Interim 2023/24 influenza A vaccine effectiveness: VEBIS European primary care and hospital multicentre studies, September 2023 to January 2024 (2024 · Eurosurveillance · 被引 51)
- Accelerated vascular ageing after COVID-19 infection: the CARTESIAN study (2025 · European Heart Journal · 被引 32)
- Effectiveness of the adapted bivalent mRNA COVID-19 vaccines against hospitalisation in individuals aged ≥ 60 years during the Omicron XBB lineage-predominant period: VEBIS SARI VE network, Europe, February to August, 2023 (2024 · Eurosurveillance · 被引 15)
- Effectiveness of the XBB.1.5 COVID‐19 Vaccines Against SARS‐CoV‐2 Hospitalisation Among Adults Aged ≥ 65 Years During the BA.2.86/JN.1 Predominant Period, VEBIS Hospital Study, Europe, November 2023 to May 2024 (2025 · Influenza and Other Respiratory Viruses · 被引 13)
- Early COVID‐19 XBB.1.5 Vaccine Effectiveness Against Hospitalisation Among Adults Targeted for Vaccination, VEBIS Hospital Network, Europe, October 2023–January 2024 (2024 · Influenza and Other Respiratory Viruses · 被引 13)